OUROFINO S.A. — Investor Relations & Filings
Ourofino S.A. specializes in the research, development, production, and commercialization of veterinary pharmaceuticals and agro-science solutions. The company operates through specialized divisions focused on animal health and crop protection. Its animal health portfolio encompasses a comprehensive range of vaccines, medicines, and veterinary drugs designed for livestock and companion animals. In the agro-science sector, the organization utilizes advanced manufacturing facilities to produce modern crop protection products. Ourofino serves a broad market including farmers, agribusinesses, cooperatives, and retailers, supported by an extensive commercial and technical team. The company prioritizes the integration of innovative technologies to address global agricultural and veterinary requirements, providing integrated solutions across the agribusiness value chain.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| - | 2026-06-02 | Portuguese | |
| FRE - Formulário de Referência | 2026-06-02 | Portuguese | |
| Reconhecer a renúncia apresentada pelo conselheiro de administração Sr. Hiroshi Kakio, conforme carta de renúncia apresentada à Companhia em 15 de maio de 2026, que fica arquivada na sede social da Co | 2026-06-02 | Portuguese | |
| FCA - Formulário Cadastral | 2026-05-26 | Portuguese | |
| Informe do Código de Governança | 2026-05-19 | Portuguese | |
| FRE - Formulário de Referência | 2026-05-05 | Portuguese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 47958329 | - | 2026-06-02 | Portuguese | ||
| 47958326 | FRE - Formulário de Referência | 2026-06-02 | Portuguese | ||
| 47958255 | Reconhecer a renúncia apresentada pelo conselheiro de administração Sr. Hiroshi Kakio, conforme carta de renúncia apresentada à Companhia em 15 de maio de 2026, que fica arquivada na sede social da Co | 2026-06-02 | Portuguese | ||
| 47845764 | FCA - Formulário Cadastral | 2026-05-26 | Portuguese | ||
| 46695521 | Informe do Código de Governança | 2026-05-19 | Portuguese | ||
| 41986070 | FRE - Formulário de Referência | 2026-05-05 | Portuguese | ||
| 33696104 | - | 2026-04-06 | Portuguese | ||
| 33797878 | DFP 2025 | 2026-03-05 | Portuguese | ||
|
2025
6 filings
| |||||
| 34114318 | ITR 2025-Q3 | 2025-11-06 | Portuguese | ||
| 34114354 | ITR 2025-Q2 | 2025-08-07 | Portuguese | ||
| 46905060 | FRE WEB 2025 | 2025-05-26 | Portuguese | ||
| 34114254 | ITR 2025-Q1 | 2025-05-15 | Portuguese | ||
| 33788850 | DFP 2024 v2 | 2025-03-17 | Portuguese | ||
| 33788814 | DFP 2024 | 2025-03-13 | Portuguese | ||
|
2024
1 filing
| |||||
| 46903695 | FRE WEB 2024 v4 | 2024-11-11 | Portuguese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Hindustan Bio Sciences Ltd.
Develops and distributes biotech-derived products and pharm…
|
532041 | IN | Manufacturing |
|
HINOVA PHARMACEUTICALS INC.
Clinical-stage developer of cancer and metabolic disease sm…
|
688302 | CN | Manufacturing |
|
Hin Sang Group (International) Holding Co. Ltd.
Develops and distributes children's healthcare, TCM, person…
|
6893 | HK | Manufacturing |
|
HISAMITSU PHARMACEUTICAL CO.,INC.
A pharmaceutical firm specializing in external pain relief …
|
4530 | JP | Manufacturing |
|
HK inno.N Corporation
A biohealth company developing pharmaceuticals and consumer…
|
195940 | KR | Manufacturing |
|
HLB Genex, Inc.
Develops and produces customized enzyme and microbiome-base…
|
187420 | KR | Manufacturing |
|
HLB INC.
A biopharmaceutical company developing new global anti-canc…
|
028300 | KR | Manufacturing |
|
HLB Life Science CO.,LTD.
Develops anti-cancer drugs and manufactures in vitro diagno…
|
067630 | KR | Manufacturing |
|
HLB Pep Co., Ltd.
Biopharmaceutical firm specializing in peptide-based drug R…
|
196300 | KR | Manufacturing |
|
HLB PHARMACEUTICAL CO., LTD.
Develops and manufactures pharmaceuticals, quasi-drugs, and…
|
047920 | KR | Manufacturing |
OUROFINO S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53118/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53118 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53118 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53118 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53118}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OUROFINO S.A. (id: 53118)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.